MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,960,334 | -5.0% | 343,442 | -21.2% | 0.00% | 0.0% |
| Q2 2023 | $15,754,414 | -1.6% | 436,048 | +1.3% | 0.00% | -20.0% |
| Q1 2023 | $16,005,767 | -18.2% | 430,494 | -0.3% | 0.01% | -16.7% |
| Q4 2022 | $19,572,244 | -30.7% | 431,963 | +6.9% | 0.01% | -40.0% |
| Q3 2022 | $28,228,000 | +7.0% | 404,174 | +2.9% | 0.01% | +11.1% |
| Q2 2022 | $26,376,000 | -18.4% | 392,900 | -0.0% | 0.01% | -10.0% |
| Q1 2022 | $32,310,000 | -42.4% | 392,958 | +2.8% | 0.01% | -41.2% |
| Q4 2021 | $56,099,000 | -8.6% | 382,429 | +10.2% | 0.02% | -15.0% |
| Q3 2021 | $61,393,000 | +11.0% | 347,025 | +1.4% | 0.02% | +11.1% |
| Q2 2021 | $55,287,000 | -22.6% | 342,268 | -17.9% | 0.02% | -30.8% |
| Q1 2021 | $71,398,000 | -19.9% | 416,798 | +2.7% | 0.03% | -25.7% |
| Q4 2020 | $89,100,000 | +54.0% | 405,663 | +16.5% | 0.04% | +29.6% |
| Q3 2020 | $57,840,000 | +93.9% | 348,328 | +33.3% | 0.03% | +80.0% |
| Q2 2020 | $29,828,000 | +70.1% | 261,255 | +14.5% | 0.02% | +50.0% |
| Q1 2020 | $17,537,000 | -30.2% | 228,136 | +17.0% | 0.01% | -28.6% |
| Q4 2019 | $25,135,000 | +70.0% | 195,051 | +2.8% | 0.01% | +55.6% |
| Q3 2019 | $14,786,000 | -20.4% | 189,771 | +5.2% | 0.01% | -18.2% |
| Q2 2019 | $18,572,000 | +49.6% | 180,306 | +6.5% | 0.01% | +37.5% |
| Q1 2019 | $12,411,000 | +90.8% | 169,314 | +10.4% | 0.01% | +60.0% |
| Q4 2018 | $6,505,000 | -10.4% | 153,326 | -0.5% | 0.01% | 0.0% |
| Q3 2018 | $7,260,000 | +240.4% | 154,120 | +256.3% | 0.01% | +150.0% |
| Q2 2018 | $2,133,000 | +792.5% | 43,257 | +457.6% | 0.00% | – |
| Q1 2018 | $239,000 | +132.0% | 7,758 | -60.5% | 0.00% | – |
| Q1 2017 | $103,000 | +19.8% | 19,648 | +8.9% | 0.00% | – |
| Q4 2016 | $86,000 | -28.3% | 18,048 | 0.0% | 0.00% | – |
| Q3 2016 | $120,000 | +21.2% | 18,048 | 0.0% | 0.00% | – |
| Q2 2016 | $99,000 | -74.4% | 18,048 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $387,000 | -32.2% | 18,048 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $571,000 | +16.3% | 18,048 | +26.7% | 0.00% | 0.0% |
| Q3 2015 | $491,000 | +9.4% | 14,248 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $449,000 | +45.8% | 14,248 | +35.7% | 0.00% | – |
| Q1 2015 | $308,000 | +57.9% | 10,500 | 0.0% | 0.00% | – |
| Q4 2014 | $195,000 | +6.0% | 10,500 | 0.0% | 0.00% | – |
| Q3 2014 | $184,000 | -12.4% | 10,500 | 0.0% | 0.00% | – |
| Q2 2014 | $210,000 | – | 10,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |